The Palico Private Equity Fund Marketplace
BB Biotech Ventures is a private equity general partner firm.
Aleva Neurotherapeutics, a Swiss developer of next-generation implants for deep brain stimulation, has collected $18m in a Series C round.
Atlas Genetics, which develops diagnostic tests for infectious diseases, raised $20m in Series C funding from BB Biotech Ventures and others
Swiss biotech Molecular Partners, backed by several VCs, is planning to raise CHF96m in an IPO on the Swiss Exchange.
Read more news concerning BB Biotech Ventures
A sampling of BB Biotech Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?